Clinical Trials Directory

Trials / Completed

CompletedNCT05691725

Evaluation of Peripheral Neutrophils in Antisynthetase Syndrome

Evaluation of Peripheral Neutrophils in Patients With Antisynthetase Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Antisynthetase syndrome (AS) is a rare overlapping myositis characterized by cellular and humoral autoimmune responses directed against aminoacyl-tRNA synthetases. A pathogenic role of neutrophils was described during inflammatory myopathies, with increased netosis correlated with disease activity and muscle damage. Higher number of alveolar neutrophils was observed in patients with rapidly progressive forms of interstitial lung disease. Peripheral neutrophils could represent a simple biomarker of severity and activity in patients with antisynthetase syndrome. The main objective is to compare circulating neutrophils between severe and non severe patients with antisynthetase syndrome. Secondary objectives are: 1) to evaluate correlation between circulating neutrophils and organ-specific severity, 2) to compare circulating neutrophils at time of diagnosis and circulating neutrophils after 6 months of treatment in patients with antisynthetase syndrome.

Conditions

Timeline

Start date
2023-02-01
Primary completion
2023-04-01
Completion
2023-04-01
First posted
2023-01-20
Last updated
2023-08-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05691725. Inclusion in this directory is not an endorsement.